Search
Neurosense Therapeutics Ltd
NRSNAdd to Watchlist
6.350USD
-0.370-5.51%
Close 09-18 16:00（ET）
213.90MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-5.51%
5 Days
-8.50%
1 Month
-20.23%
6 Months
-59.76%
Year to Date
-58.71%
1 Year
-73.98%
Key Figures
6.990Open
6.990High
300.00Volume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.00%Turnover Ratio
6.720Prev. Close
6.350Low
1.98KTurnover
LossP/E Static
-137.12P/B
0.00%Div Yield TTM
-397.11%ROA
7.50052wk High
0.00Volume Ratio
-10.21MNet Profit
32.56MShares
-0.4366EPS TTM
1.57Beta
-2174.98%ROE
5.00052wk Low
0.59%Amplitude
--Gross Margin
213.90MMarket Cap
-6.41Reward/Risk
119.58%Risk Rate
More news coming soon, stay tuned...
Analyst Rating
Neurosense Therapeutics Ltd Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2025
Earnings / Forecast
-0.44/--
Revenue / Forecast
--/--
Neurosense Therapeutics Ltd Profile
SectorBiotechnology & Medical Research
Ticker SymbolNRSN
Number of employees15
CountryIsrael
Ownership
| Shareholders | Proportion |
|---|---|
| Ben-Noon (Alon) | 11.82% |
| Rimon Gold Assets Ltd | 9.34% |
| Eisenberg (Or) | 3.55% |
| Tracik (Ferenc) | 1.75% |
| Shareholder Types | Proportion |
|---|---|
| Individual Investor | 22.97% |
| Corporation | 9.34% |
| Investment Advisor/Hedge Fund | 0.41% |
| Investment Advisor | 0.37% |
Related Instruments
+0.04%
-0.09%
-0.04%
-0.02%
-0.19%
-0.39%
+1.55%
-0.52%
+0.07%
+0.12%
+0.35%
-1.55%
-1.65%
-1.53%
-0.56%
-0.58%
-0.55%
-2.55%
-0.73%
-0.42%Popular Instruments
51734.000
-26.000 (-0.05%)
29664.700
+252.000 (+0.86%)
7659.100
+27.000 (+0.35%)
14420.000
+119.000 (+0.83%)
65079.000
+130.000 (+0.20%)
6230.800
-76.400 (-1.21%)
96.001
-1.985 (-2.03%)
336.130
-0.870 (-0.26%)
222.270
+2.930 (+1.34%)
4377.330
+36.350 (+0.84%)
FAQs
What is the current price of Neurosense Therapeutics Ltd (NRSN)?
The current price of Neurosense Therapeutics Ltd (NRSN) is 6.35.
What is the symbol of Neurosense Therapeutics Ltd?
The ticker symbol of Neurosense Therapeutics Ltd is NRSN.
What is the 52-week high of Neurosense Therapeutics Ltd?
The 52-week high of Neurosense Therapeutics Ltd is 7.50.
What is the 52-week low of Neurosense Therapeutics Ltd?
The 52-week low of Neurosense Therapeutics Ltd is 5.00.
What is the market capitalization of Neurosense Therapeutics Ltd?
The market capitalization of Neurosense Therapeutics Ltd is 213.90M.
Is Neurosense Therapeutics Ltd (NRSN) currently rated as Buy, Hold, or Sell?
According to analysts, Neurosense Therapeutics Ltd (NRSN) has an overall rating of Buy, with a price target of 137.50.
What is the Earnings Per Share (EPS TTM) of Neurosense Therapeutics Ltd (NRSN)?
The Earnings Per Share (EPS TTM) of Neurosense Therapeutics Ltd (NRSN) is -0.44.